We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

AUSTIN - ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a micro-cap biotech company with a market capitalization of $18.78 ...

Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases, today announced it has granted Immunome, Inc. (Nasdaq: IMNM) ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform therapeutic development. By ...

AbCellera is expanding its collaboration with pharmaceutical company AbbVie to include the discovery of T-cell engagers in oncology. The new agreement will see the Canadian developer of antibody ...

AMd (AMD) said via X that it is partnering with drug-discovery company Absci (ABSI). “AMD is proud to announce we are partnering with @abscibio ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

IPA is poised to lead the next wave of AI-powered drug discovery. About ImmunoPrecise Antibodies Ltd. ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling ...